EUVIMEDEUVIMED entdecken
Fallbericht

Diagnosis And Management Of Von Willebrand Disease Type 3 In An Adolescent Girl Presenting With First-Episode Menorrhagia And Severe Anemia: Case Report

Ashikesh K. Gangade, Priyanka D. Nikam, Deepali S Rajput, Kalpana B. Ayare

International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)

DOI: 10.25258/ijddt.16.28s.77 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von Ashikesh K. Gangade und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Von willebrand disease (vwd) is a common inherited bleeding disorder characterized by quantitative or qualitative deficiencies in von willebrand factor, which ultimately impairs platelet adhesion and reduces the stabilization of coagulation factor viii. This case report presents the clinical journey of a 13-year-old girl who experienced a lifethreatening first-episode of menarche, manifesting as persistent per-vaginal bleeding for 11 days. At presentation, the patient exhibited severe pallor and profound anemia, with a hemoglobin level of 4.6 g/dl. Her clinical history was further notable for delayed wound healing and a prior requirement for blood transfusion at three years of age, suggesting an undiagnosed congenital coagulopathy. Laboratory evaluation demonstrated an activated partial thromboplastin time of 60.1 seconds, a bleeding time greater than 10 minutes, and a factor viii level of 2.8%. Further specialized assays revealed a ristocetin cofactor activity of 21% and a von willebrand antigen level of less than 2.2, confirming the diagnosis of type 3 von willebrand disease with severe secondary factor viii deficiency. Initial clinical stabilization was achieved through the administration of two blood transfusions, followed by the use of tranexamic acid and vitamin k. Hemostasis was definitively achieved after the targeted administration of purified freeze-dried human coagulation factor viii at a calculated dose of 750 iu/day for her 50 kg body weight. This case highlights the vital importance of early recognition and systematic screening for inherited bleeding disorders in adolescent girls presenting with heavy menstrual bleeding, particularly when accompanied by lifethreatening anemia and a suggestive pediatric bleeding history

Zitieren

APA

Gangade, A. K., Nikam, P. D., Rajput, D. S., & Ayare, K. B. (2026). Diagnosis And Management Of Von Willebrand Disease Type 3 In An Adolescent Girl Presenting With First-Episode Menorrhagia And Severe Anemia: Case Report. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.77

Vancouver

Gangade AK, Nikam PD, Rajput DS, Ayare KB. Diagnosis And Management Of Von Willebrand Disease Type 3 In An Adolescent Girl Presenting With First-Episode Menorrhagia And Severe Anemia: Case Report. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.77

BibTeX
@article{Gangade2026,
  author = {Gangade, Ashikesh K. and Nikam, Priyanka D. and Rajput, Deepali S and Ayare, Kalpana B.},
  title = {Diagnosis And Management Of Von Willebrand Disease Type 3 In An Adolescent Girl Presenting With First-Episode Menorrhagia And Severe Anemia: Case Report},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {28s},
  doi = {10.25258/ijddt.16.28s.77}
}
Kostenlos starten →